{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-024997","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2023-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.043472+00:00","generated_at":"2026-06-19T00:56:36.391832+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Anzu SPAC enters extension support agreements to push deadline to Sept 30, 2023; target Envoy Medical","bullets":["Entered Extension Support Agreements with unaffiliated holders to extend business combination deadline from March 4 to Sept 30, 2023.","Sponsor to transfer up to 80,000 Founder Shares per holder for each 100,000 Public Shares retained post-extension.","Holders agreed to vote 3,311,894 Public Shares in favor of the extension proposal.","Target is Envoy Medical, a medical device company with FDA Breakthrough Device Designation; no minimum cash condition.","Extension increases likelihood of approval and may preserve trust account funds; no assurance of sufficient funds."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-024997","json":"https://secwatch.observer/filing/0001104659-23-024997.json","markdown":"https://secwatch.observer/filing/0001104659-23-024997.md","text":"https://secwatch.observer/filing/0001104659-23-024997.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000110465923024997/0001104659-23-024997-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000110465923024997/tm237723d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T00:56:36.391832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"774778f8cd0ccf83051ff122c822c1448be5927d","claim":"Envoy Medical, Inc. entered into Extension Support Agreements with several unaffiliated third parties (Holders) valued at Sponsor agreed to transfer up to 80,000 Founder Shares per Holder for every 100,000 Public Shares re (effective 2023-02-23).","evidence_excerpt":"On February 23, 2023, in connection with the special meeting of stockholders (the “ Special Meeting ”) of Anzu Special Acquisition Corp I, a Delaware corporation (the “ Company ”), to extend the date by which the Company has to consummate a business combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Company’s board of directors (the “ Extension Amendment Proposal ”), the Company and Anzu SPAC GP I LLC (the “ Sponsor ”) entered into extension support agreements (the “ Extension Support Agreements ”) with several unaffiliated third parties (each, a “ Holder ”), pursuant to which each Holder agreed to (i) notify the Sponsor at least three business days prior to the Special Meeting regarding the number of shares of the Company’s Class A common stock (“ Public Shares ”) that such Holder intends to redeem and the number of Public Shares that such Holder intends to retain in connection with the Special Meeting and (ii) vote (and to cause its control","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000110465923024997/0001104659-23-024997-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"several unaffiliated third parties (Holders)"},{"label":"Value","value":"Sponsor agreed to transfer up to 80,000 Founder Shares per Holder for every 100,000 Public Shares re"},{"label":"Effective","value":"2023-02-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}